Douglas Barry - 14 Oct 2021 Form 3 Insider Report for Tango Therapeutics, Inc. (TNGX)

Role
General Counsel, Corporate Secretary
Signature
/s/ Douglas Barry
Issuer symbol
TNGX
Transactions as of
14 Oct 2021
Net transactions value
$0
Form type
3
Filing time
01 Nov 2021, 16:15:12 UTC
Next filing
03 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding TNGX Stock Option (Right to Buy) 14 Oct 2021 Common Stock 246,296 $9.56 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option shall vest and become exercisable over a four-year period, at a rate of 25% on August 2, 2022, with the remaining option shares vesting in 36 equal monthly installments thereafter.

Remarks:

General Counsel, Corporate Secretary